Cargando…
Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
BACKGROUND: To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this stu...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257392/ https://www.ncbi.nlm.nih.gov/pubmed/37304882 http://dx.doi.org/10.7717/peerj.15515 |
_version_ | 1785057292019826688 |
---|---|
author | Zhang, Xihong Qian, Chungen Yang, Li Gao, Huixia Jiang, Ping Dai, Muwei Wang, Yuling Kang, Haiyan Xu, Yi Hu, Qian Feng, Fumin Cheng, Bangning Dai, Erhei |
author_facet | Zhang, Xihong Qian, Chungen Yang, Li Gao, Huixia Jiang, Ping Dai, Muwei Wang, Yuling Kang, Haiyan Xu, Yi Hu, Qian Feng, Fumin Cheng, Bangning Dai, Erhei |
author_sort | Zhang, Xihong |
collection | PubMed |
description | BACKGROUND: To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this study, we sought to investigate the value of serum SARS-CoV-2 N-Ag for COVID-19 diagnosis and to analyze N-Ag characteristics in COVID-19 individuals. METHODS: Serum samples collected from 215 COVID-19 patients and 65 non-COVID-19 individuals were used to quantitatively detect N-Ag via chemiluminescent immunoassay according to the manufacturer’s instructions. RESULTS: The sensitivity and specificity of the N-Ag assay were 64.75% (95% confidence interval (95% CI) [55.94–72.66%]) and 100% (95% CI [93.05–100.00%]), respectively, according to the cut-off value recommended by the manufacturer. The receiver operating characteristic (ROC) curve showed a sensitivity of 100.00% (95% CI [94.42–100.00%]) and a specificity of 71.31% (95% CI [62.73–78.59%]). The positive rates and levels of serum SARS-CoV-2 N-Ag were not related to sex, comorbidity status or disease severity of COVID-19 (all P < 0.001). Compared with RT‒PCR, there was a lower positive rate of serum N-Ag for acute COVID-19 patients (P < 0.001). The positive rate and levels of serum SARS-CoV-2 N-Ag in acute patients were significantly higher than those in convalescent patients (all P < 0.001). In addition, the positive rate of serum SARS-CoV-2 N-Ag in acute COVID-19 patients was higher than that of serum antibodies (IgM, IgG, IgA and neutralizing antibodies (Nab)) against SARS-CoV-2 (all P < 0.001). However, the positive rate of serum SARS-CoV-2 N-Ag in convalescent COVID-19 patients was significantly lower than that of antibodies (all P < 0.001). CONCLUSION: Serum N-Ag can be used as a biomarker for early COVID-19 diagnosis based on appropriate cut-off values. In addition, our study also demonstrated the relationship between serum N-Ag and clinical characteristics. |
format | Online Article Text |
id | pubmed-10257392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102573922023-06-11 Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients Zhang, Xihong Qian, Chungen Yang, Li Gao, Huixia Jiang, Ping Dai, Muwei Wang, Yuling Kang, Haiyan Xu, Yi Hu, Qian Feng, Fumin Cheng, Bangning Dai, Erhei PeerJ Immunology BACKGROUND: To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this study, we sought to investigate the value of serum SARS-CoV-2 N-Ag for COVID-19 diagnosis and to analyze N-Ag characteristics in COVID-19 individuals. METHODS: Serum samples collected from 215 COVID-19 patients and 65 non-COVID-19 individuals were used to quantitatively detect N-Ag via chemiluminescent immunoassay according to the manufacturer’s instructions. RESULTS: The sensitivity and specificity of the N-Ag assay were 64.75% (95% confidence interval (95% CI) [55.94–72.66%]) and 100% (95% CI [93.05–100.00%]), respectively, according to the cut-off value recommended by the manufacturer. The receiver operating characteristic (ROC) curve showed a sensitivity of 100.00% (95% CI [94.42–100.00%]) and a specificity of 71.31% (95% CI [62.73–78.59%]). The positive rates and levels of serum SARS-CoV-2 N-Ag were not related to sex, comorbidity status or disease severity of COVID-19 (all P < 0.001). Compared with RT‒PCR, there was a lower positive rate of serum N-Ag for acute COVID-19 patients (P < 0.001). The positive rate and levels of serum SARS-CoV-2 N-Ag in acute patients were significantly higher than those in convalescent patients (all P < 0.001). In addition, the positive rate of serum SARS-CoV-2 N-Ag in acute COVID-19 patients was higher than that of serum antibodies (IgM, IgG, IgA and neutralizing antibodies (Nab)) against SARS-CoV-2 (all P < 0.001). However, the positive rate of serum SARS-CoV-2 N-Ag in convalescent COVID-19 patients was significantly lower than that of antibodies (all P < 0.001). CONCLUSION: Serum N-Ag can be used as a biomarker for early COVID-19 diagnosis based on appropriate cut-off values. In addition, our study also demonstrated the relationship between serum N-Ag and clinical characteristics. PeerJ Inc. 2023-06-07 /pmc/articles/PMC10257392/ /pubmed/37304882 http://dx.doi.org/10.7717/peerj.15515 Text en © 2023 Zhang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Immunology Zhang, Xihong Qian, Chungen Yang, Li Gao, Huixia Jiang, Ping Dai, Muwei Wang, Yuling Kang, Haiyan Xu, Yi Hu, Qian Feng, Fumin Cheng, Bangning Dai, Erhei Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients |
title | Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients |
title_full | Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients |
title_fullStr | Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients |
title_full_unstemmed | Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients |
title_short | Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients |
title_sort | diagnostic value and characteristic analysis of serum nucleocapsid antigen in covid-19 patients |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257392/ https://www.ncbi.nlm.nih.gov/pubmed/37304882 http://dx.doi.org/10.7717/peerj.15515 |
work_keys_str_mv | AT zhangxihong diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT qianchungen diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT yangli diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT gaohuixia diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT jiangping diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT daimuwei diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT wangyuling diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT kanghaiyan diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT xuyi diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT huqian diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT fengfumin diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT chengbangning diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients AT daierhei diagnosticvalueandcharacteristicanalysisofserumnucleocapsidantigenincovid19patients |